Luminescent bioassay techniques have been widely adopted in a variety of research and medical institutions. However, conventional luminescent bioassays utilizing traditional bioprobes like organic dyes and quantum dots often suffer from the interference of background noise from scattered lights and autofluorescence from biological matrices. To eliminate this disadvantage, the use of inorganic lanthanide (Ln 3+ )-doped nanoparticles (NPs) is an excellent option in view of their superior optical properties, such as the long-lived downshifting luminescence, near-infrared triggered anti-Stokes upconverting luminescence and excitation-free persistent luminescence. In this review, we summarize the latest advances in the development of inorganic Ln 3+ -doped NPs as sensitive luminescent bioprobes from their fundamental physicochemical properties to biodetection, including the chemical synthesis, surface functionalization, optical properties and their promising applications for background-free luminescent bioassays. Future efforts and prospects towards this rapidly growing field are also proposed.
INTRODUCTION
Sensitive and specific bioassay of trace amount of target analytes is essential for a variety of biomedical applications ranging from pharmaceutical preparation to disease diagnosis and therapy [1] [2] [3] . Among various bioassay methods, luminescent bioassay has received particular attention because of its high sensitivity and good specificity [4, 5] . Conventional luminescent bioassay techniques such as enzyme-linked immunosorbent assay (ELISA), time-resolved (TR) fluoroimmunoassay (TRFIA), Förster resonance energy transfer (FRET) and TR-FRET assays have laid the foundation for many modern clinical applications [6] [7] [8] [9] [10] [11] . However, these bioassays are impeded by the availability of traditional bioprobes like organic dyes, lanthanide (Ln 3+ ) chelates and quantum dots (QDs). The use of these bioprobes has a number of limitations. Organic dyes commonly possess poor photochemical stability and suffer from serious photobleaching [12] . The applicability of QDs is compromised by photoblinking and high toxic-ity of heavy metal elements like cadmium and selenium, especially for in vivo biosensing [13, 14] . Moreover, both organic dyes and QDs may induce high background noise and considerable photodamage to the biological samples under ultraviolet (UV) excitation, which deteriorates their detection sensitivity for bioassays [15, 16] . Although such background noise can be suppressed by the technique of TR photoluminescence (PL) through the use of the longlived luminescence of Ln 3+ -chelates, the poor photochemical stability, long-term toxicity and high cost of Ln 3+ -chelates remain a major issue [17] . These concerns fuel a crucial demand for the development of a new generation of luminescent bioprobes to circumvent the limitations of traditional ones.
Recently, with the explosion of nanoscience and nanotechnology, there is a growing dedication towards the development of diverse luminescent nanoprobes for biodetection and bioimaging. Representative of these nanoprobes includes Au nanoparticles (NPs) [18, 19] , carbon nanomaterials (e.g., carbon dots and graphenes) [20] [21] [22] , polymer NPs [23] , silicon NPs [24] and inorganic Ln 3+ -doped NPs [16, 25] , etc. Among these nanomaterials, Ln 3+ -doped NPs are most intriguing due to their superior physicochemical properties, such as long-lived luminescence (from several to tens of milliseconds), large antenna-generated Stokes or anti-Stokes shifts, narrow emission bands, high resistance to photobleaching and photobleaking, and low toxicity [23, 24] . Therefore, they are emerging as promising next-generation luminescent nano-bioprobes for versatile biomedical applications. Particularly, the long-lived downshifting luminescence (DSL) and high photochemical stability of Ln 3+ -doped NPs make them ideal alternative to Ln 3+ -chelates for TRPL biodetection to eliminate the short-lived background noise from scattered lights and autofluorescence from the biological samples [26, 27] . Such unwanted background noise can also be overcome by using the unique anti-Stokes upconverting luminescence (UCL) and persistent luminescence of Ln 3+ -doped NPs. The large anti-Stokes shift of UCL under near-infrared (NIR) excitation produces a neat emission spectrum without any interference of the excitation lights and biological autofluorescence [28, 29] . The long-lasting phosphorescence (LLP) nature of persistent luminescent NPs (PLNPs) allows optical excitation before signal collection, thus providing an effective strategy to thoroughly suppress the background noise originating from in situ excitation [30] [31] [32] . These features promise Ln 3+ -doped NPs as sensitive nanoprobes for background-free luminescent bioassays.
This review summarizes the most recent advances in the development of inorganic lanthanide nano-bioprobes and their salient applications for background-free luminescent bioassays. To begin with, we present a brief overview of the chemical synthesis and surface functionalization of the nanoprobes. Next, we highlight the novel optical properties of Ln 3+ -doped NPs including DSL, UCL and LLP. Then, we exemplify several key applications of these nano-bioprobes for sensitive in vitro luminescent bioassays, with an emphasis on the background-free TRPL, UCL a nd LLP assays ( Fig. 1) . Finally, some important emerging trends and future efforts towards this active field are envisioned.
CHEMICAL SYNTHESIS AND SURFACE FUNCTIONALIZATION
For biomedical applications, there are some rigorous requirements for the bioprobes, such as bright luminescence, small size, biocompatibility and biosafety [33] [34] [35] [36] . To meet these requirements, many efforts have been dedicated to the chemical synthesis and surface functionalization of inorganic Ln 3+ -doped NPs. In this section, we provide a brief overview of the general routes to the fabrication of inorganic lanthanide luminescent nanoprobes especially for bioassay applications, including controlled synthesis, surface modification and bioconjugation.
Controlled synthesis
In the past decade, a variety of approaches have been developed for the synthesis of high-quality Ln 3+ -doped luminescent NPs with controlled crystalline phases, morphologies, sizes and desirable optical properties [37] [38] [39] [40] [41] [42] . Among the established approaches, thermal decomposition [43] [44] [45] [46] , high-temperature coprecipitation [47] [48] [49] and hydro (solvo) thermal methods [50] [51] [52] are the most popular synthetic routes. These methods commonly make use of the organic surfactants to control the nucleation and growth of the nanocrystals. The available surfactants are either hydrophilic or lipophilic. The use of hydrophilic surfactants such as ethylenediaminetetraacetic acid (EDTA) [53] , polyethylenimine (PEI) [54] , polyethylene glycol (PEG) [55] , polyacrylic acid (PAA) [56] and 2-aminoethyl dihydrogen phosphate (AEP) [27] allows for one-step synthesis of hydrophilic and biocompatible NPs, but the poor uniformity and monodispersity and the low PL efficiency of the resulting NPs restrict their widespread applications [16, 57] . Instead, the lipophilic ligands such as oleic acid (OA), oleylamine (OM) and tri-n-octylphosphine oxide (TOPO) combined with other high boiling organic solvents like 1-octadecene (ODE) and trioctylamine (TOA) provide a mild solution for the synthesis of high-quality NPs with a narrow size distribution, good crystallinity and excellent optical properties, and thus are most frequently used in the synthesis of Ln 3+ -doped NPs [43, 47, 50] . For instance, through the thermal decomposition and high-temperature coprecipitation methods in the presence of OA, OM and ODE, we have fabricated a series of monodisperse Ln 3+ -doped fluoride NPs with intense DSL and/or UCL, such as NaYF 4 [58] , NaGdF 4 [59] , NaScF 4 [60] [66] , etc.
On the nanoscale, surface quenching effect is the primary influential factor that deteriorates the PL efficiency of Ln 3+ -doped NPs, especially their UCL [67] . To surmount this disadvantage, surface passivation through core-shell architectures is a good choice. Also, the core-shell nanostructure design may endow the NPs with novel optical properties or integration of other functional modalities for diverse bioapplications [68] [69] [70] . For instance, through seed-mediated epitaxial layer-by-layer (LBL) growth, we have synthesized CaF 2 :Ln 3+ @CaF 2 NPs with multi-shells and ultrasmall particle sizes ranging from ~4 nm to ~10 nm (Figs 2a-e) [65] . It was found that the overall UCL intensity of Er 3+ and Tm 3+ in 3-monolayer (ML) core-shell NPs was enhanced by factors of ~92 and ~1,700, respectively, relative to their core-only counterparts. However, such seed-mediated heat-up synthesis is still laborious and time-consuming due to the tedious multi-cycle batch operations. Recently, more convenient approaches such as self-focusing by Ostwald ripening and one-pot successive LBL (SLBL) strategy through the alternate injection of different shell precursors have been developed to synthesize Ln 3+ -doped core-shell NPs [71] [72] [73] . Inspired by the 
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SLBL method, we further designed a unique strategy for the synthesis of multi-shell LiLuF 4 : Ln 3+ @LiLuF 4 upconversion (UC) NPs via thermal decomposition (Figs 2f-i) [62] . It was observed that the overall UCL intensity was remarkably enhanced upon successive shell passivation. The absolute UC quantum yields (QYs) of Er  3+ and Tm   3+ were, respectively, improved from 0.11% and 0.61% in the core-only NPs to 5.0% and 7.6% in 16-ML core-shell NPs, upon 980 nm laser excitation at a power density of 127 W cm −2
. To the best of our knowledge, the UC QYs of 5.0% and 7.6% for Er 3+ and Tm 3+ are the highest among those Ln 3+ -doped UCNPs ever reported, under NIR excitation at equivalent power density. Compared with the previous methods, our strategy is much easier to handle without the need for the precipitation of core NPs and the tedious multi-cycle operations or the alternate injection of different shell precursors, thus providing a more facile and general synthetic route for Ln 3+ -doped core-shell NPs .
Surface modification
The synthesized Ln 3+ -doped NPs aforementioned, in most cases, are hydrophobic and incompatible with biological systems due to the lipophilic ligands such as OA or OM capping on their surface. A general solution to this problem is the surface modification of the hydrophobic NPs with a hydrophilic ligand bearing appropriate functional groups [74] . For this purpose, a number of surface modification strategies such as ligand exchange [75] [76] [77] 
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tion [78, 79] , ligand-free synthesis [80] , ligand attraction [81, 82] , electrostatic layer-by-layer assembly [83, 84] and surface silanization [85, 86] have been established (Fig. 3) .
Ligand exchange is one of the most general and efficient approaches to convert hydrophobic Ln 3+ -doped NPs into hydrophilic ones. In a typical ligand exchange procedure, organic molecules or polymers with hydrophilic moieties (e.g., PEI, PEG, PAA and AEP) are employed to exchange the lipophilic surfactants of the original NPs, which endow the NPs with high water solubility and additional functional groups (e.g., amino, carboxylic and thiol groups) for subsequent bioconjugation [75] [76] [77] . Ligand oxidation is primarily based on the oxidation of the unsaturated carbon-carbon double bonds of the capping ligands (e.g., OA), and thus is only applicable to a limit number of organic surfactants [78, 79] . The capping ligands anchored on the surface of the original NPs can be removed through a simple acid (or excess ethanol) treatment process to yield water-soluble and ligand-free NPs. The removal of the capping ligands makes the positively charged Ln 3+ ions exposed on the surface of the ligand-free NPs, enabling the NPs for direct conjugation with electronegative groups of hydrophilic and biocompatible molecules for further bioapplications [80, 87, 88] . The approach of ligand attraction mainly takes advantage of hydrophobic-hydrophobic van der Waals interactions between selected amphiphilic polymers and original lipophilic ligands to realize phase transformation of the NPs. In a typical ligand attraction process, the hydrophobic portion of the amphiphilic polymers interacts with the organic layer of the NPs via hydrophobic attraction, while the hydrophilic portion facing outwards interacts with the aqueous solvent and renders the NPs water-soluble [81, 82] . Besides the hydrophobic-hydrophobic interactions, the electrostatic attraction between oppositely charged organic species such as poly(allylamine hydrochloride) (PAH) and poly(styrene sulfonate) (PSS) can also be utilized to obtain hydrophilic NPs through LBL assembly around the hydrophobic NPs [83, 84] . Surface silanization or silica coating commonly makes use of an inorganic amorphous silica shell to fabricate a hybrid core-shell nanocomposite. Such an amorphous silica shell is water-soluble, photostable and biocompatible, which allows easy surface carboxyl-functionalization (or amine-functionalization) for further bioconjugation [85, 86] . Specifically, the mesoporous silica (mSiO 2 ) shell or yolk shell coating endows the NPs with excellent loading capabilities with diverse biological molecules or other functional moieties, making them ideal candidates for applications in multimodal bioimaging, targeted drug delivery and photodynamic therapy [89] [90] [91] [92] .
Bioconjugation
Bioconjugation of specific biomolecules to the surface of Ln 3+ -doped luminescent NPs is essential for their bioanalytical applications. The conjugation of biomolecules could impart the NPs with both biocompatibility and desired functionality such as the ability of specific recognition [87, [93] [94] [95] . The available biomolecules cover from small biomolecules like biotin and folic acid to biomacromolecules like avidin, streptavidin, antibodies, peptides, aptamers and DNA, subjected to the expected target capabilities.
In general, the bioconjugation methods for Ln
3+
-doped NPs are based on either physical adsorption or chemical bonding or their combinations (Fig. 4) [96] [97] [98] [99] . With known isoelectric points, the ζ potentials of the NPs and the conjugating biomolecules can be readily tuned in opposite charges by adjusting the pH value of the reaction buffers, which allows for direct bioconjugation of the NPs via electrostatic attraction [100] . For example, by utilizing the positively charged Ln 3+ ions exposed on ligand-free LiLuF 4 :Yb, Er UCNPs, we have succeeded in the avidin functionalization of the UCNPs through electrostatic interaction [62] . Likewise, Lu and coworkers [101] developed an exceptionally simple strategy for the direct synthesis of DNA-func- 
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tionalized NaYF 4 :Yb,Er UCNPs from as-prepared hydrophobic ones through electrostatic interaction between the negatively charged phosphates of the DNA and the naked Ln 3+ ions on the surface of the NPs. However, such physical adsorption is not steady enough and usually yields unstable biofunctionalized NPs. By contrast, chemical bonding provides a robust and stable conjugation force, thus is more favorable for the bioconjugation of Ln 3+ -doped NPs. In most cases, the functional groups of the conjugating biomolecules can be activated to react with those of the NPs and form a tight covalent bond (e.g., amide bond). Functional groups like maleimide, thiol, carboxylic, aldehyde and amine are usually used for the attachment of biomolecules [25, 87] . For example, by utilizing the free carboxylic groups on the surface of NaYF 4 : Yb, Er UCNPs, Li and coworkers [83] [65, 102] . Despite the validity of these methods, the functional groups are omnipresent in biological systems and cannot be labeled specifically in complex biological systems. In this sense, the so-called "click-chemistry" is an attractive alternative because the functional groups involved (e.g., azido and alkyne) are hardly present in biomolecules including proteins and oligomers and thus high selectivity and high yields of biomolecules conjugation can be guaranteed [103, 104] . In addition, the strong coordination capability of the naked metal ions such as Ln 3+ on the surface of ligand-free NPs can be exploited for direct bioconjugation. For example, we synthesized biotinylated NaEuF 4 and Sr 2 YF 7 NPs based on the strong chelation of the exposed Ln 3+ ions on the surface of their ligand-free counterparts, which can be steadily dispersed in varied buffer solutions for months without any observable aggregates [66, 105] .
It is worthy of noting that the bioactivity of the conjugating biomolecules and the dispersability of the NPs should be guaranteed during bioconjugation. Furthermore, to avoid non-specific binding in subsequent bioanalytical applications, it is necessary to block the residual binding sites of the NPs after the conjugation. Bovine serum albumin (BSA) and human serum albumin (HSA) are frequently used for this purpose. -doped NPs possess superior optical characteristics, such as sharp emission peaks, large antennagenerated Stokes or anti-Stokes shifts, long PL lifetimes and high photochemical stability, which make them extremely suitable for use as an alternative to traditional luminescent bioprobes for versatile biomedical applications. In this section, we highlight the distinct optical properties of Ln 3+ -doped luminescent NPs, including their long-lived DSL, NIR-triggered UCL and excitation-free LLP that are unique for background-free luminescent bioassays.
OPTICAL PROPERTIES
Downshifting luminescence
DSL refers to the phenomenon that one high-energy photon is transformed into one or more lower energy photons. Although DSL is expected for most Ln 3+ ions in theory, intense and practically useful DSL in the visible region is generally produced by those Ln 3+ ions with large energy gaps between the emitting energy levels and the next low-lying states, such as Eu 3+ , Tb 3+ , Sm 3+ , and Dy 3+ . Since the emissions via 4f-4f transitions are parity-forbidden, these DSL emitters usually have a long PL lifetime (μs-ms range). The long-lived DSL of Ln 3+ can be easily distinguished from the short-lived background noise from biological substances by setting appropriate delay time and gate time, thus is favorable for background-free TRPL biodetection [17,106−110] .
To achieve efficient DSL from Ln 3+ -doped NPs, it is essential to select desirable host materials and optimize the dopant concentrations. Ideal host materials should possess adequate transparency within the wavelength range of interest, low phonon energy, high chemical stability, closematched lattice and low local site symmetry for Ln 3+ dopants [111] [112] [113] , which are also key dopants in UCNPs for producing efficient anti-Stokes UCL, as will be overviewed in the following subsection.
Upconverting luminescence UCL is a nonlinear optical process that converts two or more low-energy pump photons into a higher-energy output photon. Different from the UC processes via virtual energy states such as multiphoton absorption or second harmonic generation that require expensive ultra-short pulse lasers to perform the excitation, Ln 3+ -doped UCNPs generally take advantage of a more efficient energy transfer UC (ETU) process through the real intermediary levels of Ln 3+ , -doped UCNPs are ideal for use as alternatives to conventional DSL bioprobes for various biomedical applications [29, 138] .
The commonly used UCL activators are those Ln 3+ ions with metastable and long-lived intermediary energy levels acting as storage reservoirs for the pump energy, such as Er 3+ , Tm 3+ and Ho 3+ (Fig. 6a) . To facilitate the ETU process and enhance the UCL efficiency, Yb 3+ ions, with a larger NIR (~980 nm) absorption cross-section, are often codoped as sensitizers. The sensitizer Yb 3+ ions are usually heavily doped to maximize the absorption, while the doping concentrations of the activators are kept low to minimize the energy loss through cross relaxation. The typical dopant concentrations in β-NaYF 4 UCNPs are 2 at.%, 0.5 at.% and 20 at.% for Er 3+ , Tm 3+ and Yb 3+ , respectively [139] . The selection criterion for the hosts of UCNPs is identical to that of their DSL counterparts. So far, the most efficient and widely used UCNPs is Yb/Er or Yb/Tm co-doped β-NaYF 4 , though some novel UC host materials such as β-NaLuF 4 and tetragonal-phase LiLuF 4 have been newly reported to have a higher UCL efficiency [62, [140] [141] [142] [143] .
Recently, with the rapid development of Ln
3+
-doped UCNPs, many interesting UCL properties such as multicolor emission, single-band emission, broad-band emission, stimulated emission and lasing, and UCL lifetime multiplexing have been explored [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [164] [165] [166] [167] [168] [169] [170] [171] [172] . In particular, the newly-developed Nd 3+ -sensitized UCNPs are more advantageous for in vivo bioimaging than common Yb 3+ -sensitized UCNPs, since the laser-induced tissue overheating effect can be minimized by virtue of the Nd 3+ absorption at ~808 nm where the water absorption cross-section is much smaller than that at 980 nm [168] [169] [170] [171] [172] . Moreover, the commercially available inexpensive 808 nm NIR diode laser makes Nd 3+ -sensitized UCNPs more appealing in certain bioapplications.
Currently, the major bottleneck of Ln
-doped UCNPs towards their commercialization is the relatively low UC QYs due to the nonlinear UC optical nature. Therefore, it is of fundamental significance to improve both the absolute UC QYs and the absorption efficiency of Ln 3+ -doped UCNPs for practical applications. Several strategies can be exploited to enhance UCL, including multi-wavelength or pulse excitation, crystal-field modification, surface passivation, antenna effect, plasmonic enhancement and external electromagnetic-field enhancement, etc.
Long-lasting phosphorescence
LLP is an optical phenomenon that the excitation light can be stored by the material within a few minutes followed by slowly releasing upon thermal activation to emitting centers, resulting in light emission that can last for minutes to hours [173] . This phenomenon is also called afterglow or persistent luminescence. LLP is of particular interest for both in vitro biodetection and in vivo bioimaging, because the PLNPs can be excited before signal acquisition, which allows for real-time monitoring of the target analytes for more than 1 h without the need for any external illumination. Such a removal of in situ excitation in the signal analysis process provides a unique solution to circumvent the interference from tissue autofluorescence and the phototoxicity of the NPs, thereby offering high signal-to-noise ratio and sensitivity for biosensing [174] .
In order to interpret the occurrence of LLP, various mechanisms ranging from basic conceptual models to complex systems have been proposed in the past decades [175] . It is generally accepted that upon excitation, charge carriers could be caught by the so called "traps", which are long-lived energy levels inside the band gap of the host material. Initiated by the absorption of thermal energy, the charge carriers are then gradually released from these traps and return to the emitters to produce LLP. For creates trapped centers, and Eu 2+ ions act as the emitters via receiving energy from the recombination of electron-hole pairs (Fig. 7a) . The excitation energy was firstly accepted by traps and then thermally transferred to Eu 2+ to emit photons lasted for several hours [176] .
Different from DSL or UCL that are easily achieved in a variety of host materials through Ln 3+ doping, LLP can only be produced in rather small number of host matrices. Hitherto, most of the LLP studies focus on a handful of host materials such as aluminates, silicates, sulfides and phosphates [177] ) are frequently co-doped as electron traps to achieve longer and brighter LLP [177] . By proper selection of the host materials and dopant ions, intense and multicolor LLP with afterglows ranging from several minutes to hours can be realized (Fig. 7b) [179] .
Besides these traditional visible-emitting LLP phosphors, there has been increasing interest in the development of NIR-emitting PLNPs. The afterglow wavelength of these NPs falls within the tissue transparency window, which is advantageous for long-term in vivo biosensing with deep penetration. For instance, in 2007, le Masne de Chermont and coworkers [32] PLNPs. Unfortunately, the preparation of all the PLNPs aforementioned requires high-temperature calcination, while their afterglow time is not long enough for longterm in vivo probing yet. Nowadays, the major challenge of PLNPs towards biomedical applications is the synthesis of monodisperse and size-controlled PLNPs. In addition, in REVIEWS SCIENCE CHINA Materials order to improve the afterglow intensity and lasting time, it is also urgent to unravel the trapping and de-trapping mechanisms responsible for LLP in the future.
BACKGROUND-FREE LUMINESCENT BIOASSAY
By utilizing the long-lived DSL, NIR-triggered anti-Stokes UCL and excitation-free LLP of Ln 3+ -doped NPs, the background noise from scattered lights and autofluorescence from biological samples can be completely ruled out, thus providing a background-free signal for biodetection and a remarkable sensitivity than conventional fluorescent immunoassays. These NPs can be used either as direct biolabels in heterogeneous assays or as energy transfer donors in homogeneous FRET assays. The analyte concentration in both types of bioassays can be quantified by measuring the PL signal of the NPs labels and the FRET signal, respectively. Based on the unique features of these NPs, a series of sensitive luminescent bioassay techniques, such as heterogeneous TRPL bioassay, dissolution-enhanced luminescent bioassay (DELBA), UCL bioassay, homogenous TR-FRET, UC-FRET and LLP-FRET assays have been developed in recent years. In this section, we overview the latest progresses of these bioassay techniques based on inorganic lanthanide nanoprobes for background-free luminescent biodetection.
Time-resolved luminescent bioassay
By employing organic dye rhodamine B isothiocyanate (RBITC) as a phantom of short-lived background fluorescence and GdF 3 : Dy 3+ NPs as the nanoprobes, we first demonstrated the effectiveness of the TRPL technique in removing the undesired background noise in 2011 (Fig. 8a ) [26] . It was observed that the steady-state PL spectrum for the mixture of GdF 3 : Dy 3+ and RBITC was dominated by the emission of RBITC upon excitation at 272 nm, whereas only the Dy 3+ emission from the NPs was detected in the TRPL spectrum with a delay time of 50 μs and a gate time 
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of 0.8 ms (Fig. 8b) . Moreover, the PL intensity of RBITC under UV irradiation gradually decreased with the time, whereas that of GdF 3 : Dy 3+ NPs kept nearly constant, indicating the superior photostability of GdF 3 : Dy 3+ NPs (Fig.  8c) . After biotinylation, the GdF 3 : Tb 3+ NPs were further explored as sensitive nanoprobes in a heterogeneous TRPL bioassay to detect trace amounts of avidin with a limit of detection (LOD) down to 74 pM. On the basis of similar protocol, we have recently extended the TRPL bioassay technique to other Ln 3+ -NPs like CaF 2 : Ce,Tb and to the assay of tumor markers such as carcinoembryonic antigen (CEA), alpha-fetoprotein (AFP) and prostate-specific antigen (PSA) with LODs ranging from several to tens of pM [65] .
Besides the application in heterogeneous TRPL bioassays, Ln 3+ -doped NPs are also regarded as excellent energy donors in homogeneous TR-FRET assays. In a typical TR-FRET process, the energy transfer from Ln 3+ -NP donor will apparently lengthen the PL lifetime of the acceptor such as organic dyes that are intrinsically short-lived, due to the slow population of the acceptor's excited-state from the long-lived Ln 3+ 's excited state [27] . When the TR technique is applied, the PL of the acceptor lengthened by the FRET process can be readily distinguished from their intrinsically short-lived PL co-excited under UV excitation. Such a signal screening guarantees both reliability and sensitivity of the assay. By employing biotinylated NaYF 4 :Ce,Tb NPs as an energy donor and fluorescein isothiocyanate (FITC)-labeled avidin as an energy acceptor, we constructed the first TR-FRET pair for the detection of avidin with an LOD of ~4.8 nM [27] . Later on, this novel TR-FRET technique was refined and extended to other Ln 3+ -NPs such as KGdF 4 : Tb 3+ and ZrO 2 : Tb 3+ NPs for avidin assays with LODs of ~5.5 nM and ~3.0 nM, respectively [102, 111] .
Since the efficiency of nonradiative FRET relies heavily on the distance between the donor and acceptor and competes with the radiative transitions of the donor, small particle size and long PL lifetime of the donor are highly desirable. To maximize the FRET efficiency and achieve a lower detection limit, we developed a unique strategy through sodium co-doping for the synthesis of ultrasmall (~3.8 nm) and highly emissive (QY of 51%) CaF 2 : Ce,Tb NPs with a long PL lifetime (~12.5 ms) for TR-FRET bioassay [65] . As a proof-of-concept experiment, the biotinylated CaF 2 : Ce,Tb NPs and FITC-labeled avidin were selected to construct a TR-FRET pair, where the excitation energy was transferred from the NP donor to a nearby acceptor FITC through specific binding (Fig. 9a) . As a result, avidin can be quantified by measuring the ratio of the integrated PL intensities of FITC and Tb , as denoted by FITC 520 / Tb 491 . The FITC 520 for the TR-FRET signal was gradually enhanced at the expense of the Tb 491 signal with the increased amount of avidin (Fig. 9b) , indicating the specific binding between avidin and biotin as well as the occurrence of FRET. By contrast, in non-binding control experiments where the biotinylated NPs (or FITC-labeled avidin) were replaced with non-biotinylated NPs (or FITC labeled BSA) under otherwise identical conditions, the TR-FRET signal was hardly observed, thus verifying the high specificity of the assay. Benefiting from the enhanced FRET efficiency through the use of ultrasmall NPs, an improved LOD of ~164 pM was realized for avidin as compared to previous TR-FRET bioassays (Fig. 9c) . Furthermore, for the first time, we explored these TR-FRET nano-bioprobes for the detection of an important tumor marker soluble uPA receptor (suPAR) with an LOD of ~328 pM, which is comparable to the serum level in cancer patients (Figs 9d and e) .
Despite these achievements, inorganic Ln 3+ -NPs still suffer from a low brightness (i.e., external QY) when compared with Ln 3+ -chelates due to their weak absorption, which limits their detection sensitivity in bioassays. To circumvent this limitation, the antenna of Ln 3+ -chelates can be hybridized with Ln 3+ -NPs to enhance their PL and simultaneously increase the labeling ratio of Ln 3+ per biomolecule in bioassays. Following this concept, we recently developed a unique and ultrasensitive bioassay method, namely DEL-BA, by simply replacing Ln 
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hanced lanthanide fluoroimmunoassay (DELFIA) (Fig. 10 ) [105] . As a result of the highly concentrated Ln 3+ ions in a single NP, a much higher labeling ratio of Ln 3+ ions per biomolecule (~4300 vs. ~30) can be achieved. Upon dissolution of the NPs by the enhancer solution, a myriad of Ln 3+ ions can be released and transformed into highly luminescent Ln 3+ micelles, which significantly amplifies the TRPL signal and thus greatly improves the detection sensitivity. By employing sub-10 nm NaEuF 4 NPs along with the 2-naphthoyltrifluoroacetone (β-NTA) enhancer solution, an unprecedented amplification (10 6 times) of the PL signal of the dissolved NPs was obtained. Utilizing such intense dissolution-enhanced PL, we achieved the detection of CEA in human serum samples with an LOD as low as 0.1 pg mL −1 (0.5 fM), which was an improvement of 3 orders of magnitude on that of commercial DELFIA. The CEA levels derived from DELBA were compared with those measured independently using a commercial DELFIA kit, and a good agreement was found between both methods (Table  1) , with a correlation coefficient value of ~0.98. Parameters including the coefficient of variations (CVs; < 8%) and the recoveries (in the range of 95%-105%) of the assays further confirmed the excellent accuracy and precision of the proposed DELBA. These findings offer new opportunities towards advances in clinical bioassays, thereby opening up new avenues for the exploration of inorganic Ln 3+ -NPs in versatile bioapplications, such as early-stage cancer diagnosis. 
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Upconverting luminescent bioassay
Since the first demonstration of UCL bioassay in 1999 [182] , there has been an extensive research on Ln 3+ -doped UCNPs in various bioassay applications [183] [184] [185] [186] . One representative paradigm was reported by Tanke and coworkers [187] , who employed Y 2 O 2 S : Yb,Er submicrons as UCL probes in DNA microarrays for the detection of nucleic acid hybrids. Owing to the absence of autofluorescence under NIR excitation, the use of UC phosphors yielded a 4-fold improved LOD of 1 ng μL −1 over that using conventional DSL probe cyanin 5. For point-of-care testing, Hampl, Zuiderwijk and Niedbala et al. [188] [189] [190] independently developed a lateral-flow strip for heterogeneous UCL bioassays. In their proof-of-concept experiment, Hampl and coworkers [188] demonstrated the application of Y 2 O 2 S : Yb,Er submicrons as UCL reporters in the lateral-flow strips for the assay of human chorionic gonadotropin (hCG) with an LOD down to 10 pg mL −1 , which was at least a 10-fold improvement over the conventional DSL reporter systems such as colloidal gold or colored latex beads. To amplify the optical signal and improve the detection sensitivity, Wang and Li [184] proposed a unique UCL bioassay technique through magnetic separation. Specifically, Wang and coworkers [191] developed multiplex aptasensors for the simultaneous detection of three pathogenic bacteria by using aptamer-functionalized multicolor NaYF 4 : Ln 3+ UCNPs as bioprobes and oligonucleotide-conjugated Fe 3 O 4 NPs as magnetic separators (Fig.  11) . Through magnetic separation and concentration, extremely high sensitivity and selectivity were achieved with LODs of 25, 10, and 15 cfu mL −1 for Staphylococcus aureus, Vibrio parahemolyticus, and Salmonella typhimurium, respectively.
More recently, we designed a novel UCL biodetection system for high-throughput bioassay based on a commercial microplate reader (Synergy 4, BioTek) integrated with a 980 nm NIR diode laser as the excitation source. By employing the surface-functionalized Ln 3+ -doped UCNPs as nano-bioprobes, a number of important tumor markers like CEA, AFP, PSA, β-hCG and suPAR were successfully detected. For instance, utilizing the avidin-functionalized LiLuF 4 : Yb,Er@LiLuF 4 core-shell UCNPs as the nanoprobes, we realized the detection of β-hCG in the UCL microplate assay (Fig. 12a) [62] . It was observed that the UCL intensity of the nanoprobes gradually increased with the increased amount of β-hCG antigen and exhibited a linear dependence with the concentration of β-hCG at 0-310 ng mL −1 (Figs 12b and c) . For comparison, in non-binding control experiment, where BSA instead of β-hCG antigen was used under otherwise identical conditions, the UCL signal was hardly detectable, thus confirming the high specificity of the assay. The LOD was determined to be ~3.8 ng mL Figure 11 Schematic illustration of multiplexed UCL bioassay based on aptamer-modified UCNPs for the simultaneous detection of various pathogenic bacteria with the assistance of magnetic separation. Reprinted with permission from Ref. [191] . Copyright 2014, American Chemical Society. Apart from functionalizing as direct labels in heterogeneous UCL assays, Ln 3+ -doped UCNPs are also frequently used as energy donors in homogenous UC-FRET assays [65, 66] . The UC-FRET assay brings together both advantages of background-free signal from the UCNP donor and separation-free convenience from the homogeneous FRET assay, thus is considered as one of the most convenient bioassay methods for fast detection in practical applications. In a typical UC-FRET process, NIR excitation of the UCNP donor triggers an energy transfer from the donor to a nearby acceptor through molecular recognition, leading to the luminescence quenching of the donor or the emission of the acceptor, subject to the type of acceptor used (fluorescent or not). The commonly used acceptors are those molecules or nanomaterials with a large absorption band overlapped with the emission bands of UCNPs. For instance, based on different acceptor entities such as organic dyes, Au NPs, MnO 2 nanosheets, carbon NPs, graphene and graphene oxide (GO), Liu and coworkers [192] [193] [194] [195] [196] [197] [198] [199] [200] proposed a series of UC-FRET pairs for the detection of diverse biomolecules including glucose, thrombin, DNA, matrix metalloproteinase-2 (MMP-2), CEA, and Kanamycin, etc. For point-of-care testing, they further designed a straightforward paper-based microfluidic device (namely UC-μPAD) for UC-FRET assays based on a normal office printing sheet with a simple plotting method [192] . Similar paper-based UC-FRET platforms were also developed by Krull and coworkers [201, 202] for DNA hybridization assays.
For the detection of human immunodeficiency virus (HIV) antibody, Chu and coworkers [185] designed an UC-FRET biosensor by using the peptide-functionalized NaYF 4 : Yb,Er UCNPs as energy donors and GO as energy quenchers. The UCNP donors were initially adsorbed on the surface of GO via π-π stacking interactions and hydrophobic interactions between the peptides and GO, which resulted in a complete UCL quenching of the donor through energy transfer or electron transfer processes. Upon addition of anti-HIV-1 gp120 antibody, the adsorption was cleaved through the formation of peptide-antibody complexes, leading to the decrease in quenching efficiency and the recovery of UCL (Fig. 13a) . It was observed that the UCL intensity of the nanoprobes increased linearly with the increased concentration of HIV-1 antibody in the range from 5 to 150 nM, and the LOD was calculated to be 2 nM according to the 3σ rule (Figs 13b and c) . Similarly, by employing β-cyclodextrin (β-CD) derivative-modified NaYF 4 :Yb,Er UCNPs (CD-Cit-UCNPs) as the energy donor and rhodamine B (RB) as the energy quencher, Ding and coworkers [203] developed a novel UC-FRET platform for the sensing of cholesterol (Cho) (Fig. 14) . At the beginning, β-CD inclusion of RB (RB -CD-Cit-UCNPs) initiated the FRET process due to the close contact between the donor and nearby quencher, resulting in the quenching of the green UCL (515-565 nm) of the donor. Upon addition of cholesterol, the FRET was switched off as a result of the cholesterol-induced release of RB from the cavity of β-CD, 
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giving rise to the recovery of the green UCL. By using the red UCL (640-685 nm) as an internal reference, ratiometric detection of cholesterol was realized in the dynamic range of 10-110 μM, with an LOD down to ~3.0 μM. The cholesterol levels in human serum samples determined by the platform were compared with those measured via enzymatic method and a good agreement was found. These efforts suggest that Ln 3+ -doped UCNPs are excellent donor labels in homogeneous FRET assays and may play a critical role in clinical, food and environmental monitoring.
Persistent luminescent bioassay
The rapid advances in the field of PLNPs open a new avenue for background-free luminescent bioassays. With the benefit of afterglow nature, the PLNPs allow optical excitation before signal acquisition and thus permit biodetection without real-time external illumination, which provides a unique solution to overcome the interference of excitation light and biological autofluorescence arising from in situ excitation [30] [31] [32] .
The concept of bioassay based on PLNPs was first demonstrated by Yan and coworkers [30] for the detection of AFP in a homogeneous LLP-FRET assay. In their pioneering work, PEI-capped Ca 1. 86 Mg 0.14 ZnSi 2 O 7 : Eu 2+ , Dy 3+ PLNPs and AFP antibody-conjugated Au NPs were selected as the energy donor and quencher, respectively, to construct an inhibition FRET pair. The FRET process was initiated between the energy donor and quencher in close proximity via electrostatic interaction, giving rise to the quenching of LLP of the donor centered at ~521 nm. Once AFP was added, such a FRET process was inhibited due to desorption of Au NPs from the PLNPs, resulting in an obvious recovery of the LLP intensity (Fig. 15a) . As a result, AFP can be quantified by directly measuring the enhanced LLP intensity. Note that the PLNP donor was irradiated for 10 min before detection to eliminate the need for further excitation during the PL analysis. It was observed that the LLP intensity of the PLNPs increased linearly with the added AFP concentration in the range from 0.8 to 45.0 μg L −1 with a correlation coefficient of 0.990 (Figs  15b and c) . The LOD was determined to be 0.41 μg L −1 , comparable to those of most fluorescent and electrochemical sensors for AFP. The AFP levels in six human serum samples were also detected, which agreed well with those measured independently using a commercial ELISA kit. However, the poor dispersibility and broad size distribution of the PLNPs synthesized at a high temperature may severely deteriorate their detection sensitivity and reliability in practical applications. To increase the sensitivity and reliability of persistent luminescent assay, monodisperse and uniform-sized PLNPs with a high LLP intensity and a long afterglow time are highly demanded. To this end, wet chemical synthesis of PLNPs at lower temperature may be a good option, though it is currently of great challenge. 
REVIEWS
CONCLUSIONS AND PROSPECTS
Inorganic Ln
3+
-doped NPs have received extensive interest in recent years because of their excellent physicochemical characteristics, which make them extremely suitable for use as alternative to traditional fluorescent bioprobes like organic dyes, Ln 3+ -chelates and QDs for background-free luminescent bioassays. These nano-bioprobes, while being in its infancy, have been rapidly developed and pushed forward to a new horizon for diverse bioassays. Substantial progresses have been gained very recently, for their size/ morphology control, functionalization design, optical property optimization as well as their applications for background-free luminescent bioassays. Meanwhile, it remains many new challenges to be solved in an effort to fulfill all requirements for commercial applications.
Firstly, it is fundamentally important to develop general and economic protocols for the synthesis, surface modification and bioconjugation of high-quality Ln 3+ -doped luminescent nanoprobes that are optimized for bioassay applications without any concerns of biocompatibility, stability and long-term toxicity. It is highly demanded to establish a wet chemical synthetic route for the fabrication of monodisperse and uniform-sized PLNPs. Secondly, the PL efficiency of Ln 3+ -doped NPs should be further improved in order to increase their detection sensitivity for diverse disease biomarkers. To this end, the antenna ligand that has very large extinction coefficient might be exploited as the sensitizer to enhance their external DSL and UCL efficiency. The capability of energy storage of PLNPs can be controlled through cation incorporation and the choice of novel host materials so as to enhance their LLP intensity and lengthen the afterglow time. Thirdly, with the growing demands for in vivo tracking and imaging of biological activities, it is highly desirable to developed NIR luminescent bioprobes. Ln 3+ -doped NIR TRPL and LLP NPs are favorable for this purpose in view of their high PL efficiencies. Last but not the least, thanks to their extremely high sensitivity, all background-free luminescent bioassay techniques based on inorganic lanthanide nanoprobes such as DELBA can be further explored for non-invasive analysis of human glandular secretions such as saliva and urine where the analyte concentration might be orders of magnitude lower than in human serum. Such saliva or urine based bioassays may bring new opportunity for early detection or screening of cancer, and would ultimately revolutionize current serum-based bioassays in future community or family medical service. . Adapted with permission from Ref. [30] . Copyright 2011, American Chemical Society.
